compounded glp 1 fda GLP-1 medications are trending online, but not everything you hear is true. Your health deserves accurate information—not hype. Learn More: https://healthnothype.org/ #HealthNotHype #GLP1 #PatientSafety #HealthEducation #KnowTheFacts FDA Phasing Out Compounded GLP-1

Statements Author contributions YJ: Data curation, Formal Analysis, Investigation, Software, Writing original draft

Supplementary Figure 1 (download TIF Confirmed transcript variants of GSTA1-GSTA5

Key Features: Chemical Names: BPC-157 (Body Protection Compound-157) TB-500 (Thymosin Beta-4 Fragment) Molecular Formulas: BPC-157: CHNO TB-500: CHNOS CAS Numbers: BPC-157: 137525-51-0 TB-500: 77591-33-4 Amino Acid Sequences: BPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val TB-500: Ac-Lys-Lys-Asp-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-Gly-Arg-Asp-Ala-Pro-Ala-Asn-Gly (Thymosin 4 fragment) Physical Form: Lyophilized powder Compound Class: Synthetic peptide blend Purity: 98% (HPLC) Storage Conditions: Store at 3646F (28C) in a dry, light-protected environment

2000;5:E1E15